15 April 2020

COVID-19 – VAT relief

In terms of Value-Added Tax (VAT), companies suffering from the coronavirus crisis can avoid liquidity disadvantages – in some cases, even refunds are possible

Companies particularly affected by the coronavirus crisis can defer current VAT payments to the tax office without interest. It is even possible to receive refunds of already made special VAT prepayments. Affected companies should definitely make use of this possibility and secure additional liquidity. Otherwise, in the event of payment defaults due to the coronavirus crisis, they are at risk of a double disadvantage, as VAT can also become due on outstanding payments.

Print


Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back

GSK Updates
  • 24 August 2021

    GSK Update: New marketing rules for investment management companies

    Read more
  • 23 June 2021

    GSK Update: The new German law on corporate due diligence in supply chains

    Read more
  • 21 June 2021

    GSK Update: Global data transfer: The new standard data protection clauses – What needs to be done?

    Read more
Contact person

Dr. Dirk Koch

Partner*

+49 89 288174-676

dirk.koch@gsk.de

Dr. Petra Eckl

Partner*

+49 69 710003-0

petra.eckl@gsk.de

Dominik Berka

Counsel

+49 69 710003-194

dominik.berka@gsk.de

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral